Patent details

Basic Information

Publication number:

EP2227248

PCT Application Number:

IB2008003582

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP088620646

PCT Publication Number:

WO2009077854

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

ADJUVANTED GLUCANS

French Title of Invention:

GLUCANES AVEC ADJUVANT

German Title of Invention:

ADJUVIERTE GLUKANE

SPC Number:

Dates

Filing date:

26/11/2008

Grant date:

11/06/2014

EP Publication Date:

15/09/2010

PCT Publication Date:

25/06/2009

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

15/09/2010

EP B1 Publication Date:

11/06/2014

EP B2 Publication Date:

31/01/2018

EP B3 Publication Date:

Lapsed date:

26/11/2014

Expiration date:

26/11/2028

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

24/01/2018

 

 

Name:

GlaxoSmithKline Biologicals SA

Address:

Rue de l'Institut, 89, 1330 Rixensart, Belgium (BE)

History of Owners

From:

26/11/2008

To:

01/12/2017

Name:

Novartis AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:

COSTANTINO, Paolo

Address:

Italy (IT)

2

Name:

ROMANO, Maria, Rosaria

Address:

Italy (IT)

3

Name:

BERTI, Francesco

Address:

Italy (IT)

Priority

1

Priority Number:

4396 P

Priority Date:

26/11/2007

Priority Country:

United States (US)

2

Priority Number:

133738 P

Priority Date:

01/07/2008

Priority Country:

United States (US)

Classification

IPC classification:

A61K 39/00; C08B 37/00; C12P 19/04;

Publication

European Patent Bulletin

1

Issue number:

201801

Publication date:

03/01/2018

Description:

Transfer of Rights

2

Issue number:

201805

Publication date:

31/01/2018

Description:

Patent maintained (B2 publication)

Filing date	Document type	Number of pages